The present finding together with other studies support the hypothesis that AXIN1 may be a potential biomarker to differ between IBS and endometriosis in young women, two groups of patients with gastrointestinal symptoms but normal levels of fecal calprotectin [17,64]. This evidence concerns the gene AXIN1 and irritable bowel syndrome.